23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
21–30 of 155 posts
Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#22Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#23The pros of using 23andMe has vastly outweighed any cons, real or hypothetical. Here is a pro: I was able to print out a 3 page report to give to my new doctor that described what medications I had a low / high tolerance for and what medical conditions to look out for as I grow older. My doctor was floored-- and as a result we do a few extra tests every year to keep track of a potential eye condition I am at a higher…
Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#24The data is anonymized, who cares? Good for 23andMe. We could learn very important things from that data in aggregate. We need more aggregated data in healthcare.
[1] http://arstechnica.com/tech-policy/2009/09/your-secrets-live...
Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#25The pros of using 23andMe has vastly outweighed any cons, real or hypothetical. Here is a pro: I was able to print out a 3 page report to give to my new doctor that described what medications I had a low / high tolerance for and what medical conditions to look out for as I grow older. My doctor was floored-- and as a result we do a few extra tests every year to keep track of a potential eye condition I am at a higher…
23andme doesn't provide this data. I'm assuming you exported your data to a 3rd party service. Could you share which one?
Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#26The pros of using 23andMe has vastly outweighed any cons, real or hypothetical. Here is a pro: I was able to print out a 3 page report to give to my new doctor that described what medications I had a low / high tolerance for and what medical conditions to look out for as I grow older. My doctor was floored-- and as a result we do a few extra tests every year to keep track of a potential eye condition I am at a higher…
Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#27The pros of using 23andMe has vastly outweighed any cons, real or hypothetical. Here is a pro: I was able to print out a 3 page report to give to my new doctor that described what medications I had a low / high tolerance for and what medical conditions to look out for as I grow older. My doctor was floored-- and as a result we do a few extra tests every year to keep track of a potential eye condition I am at a higher…
23andme doesn't provide this data. I'm assuming you exported your data to a 3rd party service. Could you share which one?
Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#28The pros of using 23andMe has vastly outweighed any cons, real or hypothetical. Here is a pro: I was able to print out a 3 page report to give to my new doctor that described what medications I had a low / high tolerance for and what medical conditions to look out for as I grow older. My doctor was floored-- and as a result we do a few extra tests every year to keep track of a potential eye condition I am at a higher…
23andme doesn't provide this data. I'm assuming you exported your data to a 3rd party service. Could you share which one?
Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#29The pros of using 23andMe has vastly outweighed any cons, real or hypothetical. Here is a pro: I was able to print out a 3 page report to give to my new doctor that described what medications I had a low / high tolerance for and what medical conditions to look out for as I grow older. My doctor was floored-- and as a result we do a few extra tests every year to keep track of a potential eye condition I am at a higher…
23andme doesn't provide this data. I'm assuming you exported your data to a 3rd party service. Could you share which one?
Re: 23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
#30So on one side journalists lament lack of new drug development & just the shoddy state of healthcare tech, while as soon as any new data that can potentially unlock new drug targets (23andMe) or provider better support (Google DeepMind Health) is introduced, Such efforts are quickly demonized with spread of Fear, Uncertainty and Doubt. Rather than asking important questions such as at which level the "aggregate" data…